BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 21734361)

  • 1. Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma.
    Kim M; Ju YS; Lee EJ; Kang HJ; Kim HS; Cho HC; Kim HJ; Kim JA; Lee DS; Lee YK
    Ann Lab Med; 2016 Nov; 36(6):573-82. PubMed ID: 27578511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
    Xu K; Nacheva E
    J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 1q21 abnormalities in multiple myeloma.
    Schmidt TM; Fonseca R; Usmani SZ
    Blood Cancer J; 2021 Apr; 11(4):83. PubMed ID: 33927196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SnapShot: Multiple Myeloma.
    Braggio E; Kortüm KM; Stewart AK
    Cancer Cell; 2015 Nov; 28(5):678-678.e1. PubMed ID: 26555176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive Clinicopathological Course of Myeloma with t(3;16) (q21;q22) Cytogenetic Abnormality.
    Bozkurt S; Okay M; Haznedaroğlu İ
    Turk J Haematol; 2019 Feb; 36(1):62-63. PubMed ID: 29726398
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities.
    Zhou P; Li W; Zuo S; Ma R; Yuan X; Zhu Z
    Leuk Lymphoma; 2023; 64(8):1373-1388. PubMed ID: 37300424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients.
    Weinhold N; Salwender HJ; Cairns DA; Raab MS; Waldron G; Blau IW; Bertsch U; Hielscher T; Morgan GJ; Jauch A; Davies FE; Hänel M; Cook G; Scheid C; Houlston R; Goldschmidt H; Jackson G; Kaiser MF
    Haematologica; 2021 Oct; 106(10):2754-2758. PubMed ID: 34092058
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.
    Maura F; Petljak M; Lionetti M; Cifola I; Liang W; Pinatel E; Alexandrov LB; Fullam A; Martincorena I; Dawson KJ; Angelopoulos N; Samur MK; Szalat R; Zamora J; Tarpey P; Davies H; Corradini P; Anderson KC; Minvielle S; Neri A; Avet-Loiseau H; Keats J; Campbell PJ; Munshi NC; Bolli N
    Leukemia; 2018 Apr; 32(4):1044-1048. PubMed ID: 29209044
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosomes in plasma-cell malignancies.
    Van Den Berghe H
    Eur J Haematol Suppl; 1989; 51():47-51. PubMed ID: 2697595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome findings in multiple myeloma].
    Suzuki K
    Nihon Rinsho; 1995 Mar; 53(3):568-73. PubMed ID: 7699887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New recurrent chromosome alterations in patients with multiple myeloma and plasma cell leukemia.
    Stella F; Pedrazzini E; Rodríguez A; Baialardo E; Kusminsky G; Arbelbide J; Fantl DB; Slavutsky I
    Cytogenet Genome Res; 2011; 134(4):249-59. PubMed ID: 21734361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
    Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
    Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.